We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

March 19, 2009

OSI Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. May 2, 2012

    Mylan Denied Invalidity In Cancer Drug IP Battle

    A Delaware federal judge Tuesday found in favor of Genentech Inc., Pfizer Inc. and Astellas Pharma Inc. unit OSI Pharmaceuticals Inc. in their patent infringement suit against Mylan Pharmaceuticals Inc. over its generic version of the lung cancer drug Tarceva.

1 other articles on this case. View all »

Parties

To view the parties, register now.